| Oct 17 2024 |
Insulin Overpricing Lawsuits: What Patients and Families Need to Know |
Oberheiden P.C. |
| Oct 16 2024 |
September 2024 Bounty Hunter Plaintiff Claims |
Keller and Heckman LLP |
| Oct 16 2024 |
Big AI Appetites May Cause Heartburn |
Sheppard, Mullin, Richter & Hampton LLP |
| Oct 16 2024 |
PAGA Reform May Curb Appetite for Litigation |
Sheppard, Mullin, Richter & Hampton LLP |
| Oct 16 2024 |
California Legislature Eighty-Six’s “Junk Fee Ban,” But Relief May Be Temporary |
Sheppard, Mullin, Richter & Hampton LLP |
| Oct 16 2024 |
California’s FAST Act to Go, But NLRB Delivers a New Joint-Employer Rule |
Sheppard, Mullin, Richter & Hampton LLP |
| Oct 16 2024 |
Court Dismisses Challenge to Strengthening Organic Enforcement Rule |
Keller and Heckman LLP |
| Oct 16 2024 |
Federal Appeals Court Upholds “Zero-Tolerance” Cannabis Policy Under North Carolina Law |
Bradley Arant Boult Cummings LLP |
| Oct 16 2024 |
Recent Federal Developments for October 2024 |
Bergeson & Campbell, P.C. |
| Oct 15 2024 |
Johnson & Johnson Case Sparks Concerns Over Future Excessive Health Fee Litigation |
Jackson Lewis P.C. |
| Oct 15 2024 |
New Liquor License Laws Aim to Assist Applicants in New York |
Greenberg Traurig, LLP |
| Oct 15 2024 |
European Parliament Fast Tracks Deforestation Regulation Entry into Force Amendment |
Squire Patton Boggs (US) LLP |
| Oct 15 2024 |
FSIS Extends Comment Period on Proposed Salmonella Rule |
Keller and Heckman LLP |
| Oct 15 2024 |
New Pittsburgh Ordinance Expands Medical Cannabis Drug Testing Protections |
Norris McLaughlin P.A. |
| Oct 14 2024 |
Medicare Coverage: CMS Finalizes New Pathway for Breakthrough Devices |
Foley & Lardner LLP |
| Oct 14 2024 |
Does Kamala Harris Support Marijuana Legalization? Squaring Words with Actions in an Evolving Political Environment |
Bradley Arant Boult Cummings LLP |
| Oct 14 2024 |
HHS Final Rule Targets Suspicious Billing Practices for Medical Equipment (CMS-1799-F) |
Nelson Mullins |
| Oct 12 2024 |
EFSA Publishes Reports under NAMs4NANO Project |
Bergeson & Campbell, P.C. |
| Oct 11 2024 |
Pending DEA Extension on Prescription of Controlled Substances via Telemedicine |
McDermott Will & Emery |
| Oct 11 2024 |
Weight Loss Drug Shortages Will End Soon |
McDermott Will & Emery |
| Oct 11 2024 |
Tirzepatide Shortage Resolved |
McDermott Will & Emery |
| Oct 11 2024 |
McDermott+ Check-Up (Special Regulatory Edition): October 11, 2024 |
McDermott Will & Emery |
| Oct 10 2024 |
Why Can’t Weed Be Friends? How Marijuana and Hemp Businesses Can Both Win, and Win America |
Bradley Arant Boult Cummings LLP |
| Oct 10 2024 |
Federal Court Enters Consent Decree Against Rizo Lopez Foods Linked to Listeria Outbreak |
Keller and Heckman LLP |
| Oct 10 2024 |
Federal Circuit Finds Evidence of Infringement, Willfulness, and Damages Insufficient as a Matter of Law |
Barnes & Thornburg LLP |
| Oct 10 2024 |
Health-e Law Episode 13: Overcoming Challenges to Innovation in Preventative Care with Steven Collens of MATTER [Podcast] |
Sheppard, Mullin, Richter & Hampton LLP |
| Oct 10 2024 |
No Matter How You Slice and Dice It, Conclusory Evidence Can’t Support Entire Market Value Damages |
McDermott Will & Emery |
| Oct 10 2024 |
Competition Currents | October 2024 |
Greenberg Traurig, LLP |
| Oct 9 2024 |
This Week in 340B: October 1 – 7, 2024 |
McDermott Will & Emery |
| Oct 9 2024 |
22 States Join Challenge to Massachusetts’ Question 3 |
Keller and Heckman LLP |
| Oct 9 2024 |
Reopening Restaurants in Buncombe County After Helene: What We Know Today |
Ward and Smith, P.A. |
| Oct 8 2024 |
Understanding AB 1775: The Future of Cannabis Cafes in California |
ArentFox Schiff LLP |
| Oct 8 2024 |
Rep. DeLauro Introduces Toxic Free Food Act |
Keller and Heckman LLP |
| Oct 8 2024 |
The Truth About Cannabis Edibles in Halloween Candy: Separating Myth from Reality |
Norris McLaughlin P.A. |
| Oct 7 2024 |
GLP-1 Drugs: FDA Removes Lilly’s Zepbound® and Mounjaro® (tirzepatide injection) from its Drug Shortage List |
Foley & Lardner LLP |
